Evogene and Compugen have both made headlines today. The two companies are related – Evogen was spun off of Compugen six years ago as an independent startup. Evogen will receive NIS 7.2 million from venture capital fund AquAgro. The ag-biotech startup develops improved plants for the agricultural and biofuel industries through plant genomics. A few weeks ago I wrote a post about the Evogene partnership with Rehovot-based CBD Technologies to collaborate on the improvement of cotton fiber properties.
Compugen announced yesterday its discovery of a blood-based biomarker for the diagnosis of lung cancer. The dual-listed firm (Nasdaq:CGEN) is involved in the identification and licensing of molecular level biomarkers and processes using computational biology tools. The discoveries are used in therapeutic and diagnostic products, for which it receives royalties.
Filed under: Biotech, Healthcare, Medicine | Tagged: aquagro, compugen, evogene | Leave a comment »